Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome

BACKGROUND: Acute chest syndrome (ACS) is the leading cause of mortality in sickle cell disease (SCD). The pathogenesis of ACS is complex and not entirely understood with multiple etiologies likely contributing simultaneously. One particular etiology is pulmonary vascular occlusion due to thrombosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Seaman, Craig D., Novelli, Enrico, De Castro, Laura, Ragni, Margaret V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654047/
https://www.ncbi.nlm.nih.gov/pubmed/33292674
http://dx.doi.org/10.1186/s40814-020-00715-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654047/
https://www.ncbi.nlm.nih.gov/pubmed/33292674
http://dx.doi.org/10.1186/s40814-020-00715-w

Ejemplares similares